Articles Posted in Mass Torts

Our firm’s national mass tort lawyers continuously monitor and track events in the various class action MDLs pending in the federal courts (MDL Docket #s). We track the volume of new cases being filed or transferred into each MDL every month, the trends or patterns in new case filings, and the status of bellwether trials, discovery, and other proceedings. And, of course, we track mass tort settlement amounts.

With a new year, we are starting to get a clearer picture of what we can expect in 2025 from the various mass tort MDLs, including those ready to grow and those ready to settle.

This post examines the hottest, biggest, and most compelling mass torts in 2025. If you click the individual links, we also project these settlement amounts.

This page examines silicosis lawsuits, their potential settlement amounts, and jury payouts.

Silicosis is a lung disease caused by occupational exposure to airborne silica dust particles from stone like granite, quartz, and other construction materials. Anyone who was exposed to silica dust from construction materials and has been diagnosed with silicosis may be eligible to file a silicosis lawsuit and receive financial compensation. Our silicosis lawyers explain how silicosis lawsuits work and the potential settlement value of these cases.

Latest Silicosis Legal News

Our national mass tort lawyers are currently seeking and investigating Wegovy lawsuits for individuals who used Wegovy and subsequently developed gastroparesis or related health conditions.’ This page will look at Wegovy lawsuits and their potential settlement value.

Wegovy (semaglutide) is the brand name of a prescription drug that is used for weight loss and weight management. Wegovy has been around awhile, but recent studies have found that prolonged use of this drug can significantly increase the risk of developing gastroparesis.

Until recently, the drug label for Wegovy did not contain any warning about the potential risk of gastroparesis. This has prompted a wave of product liability lawsuits alleging that the drug maker negligently failed to warn. Anyone who suffered gastroparesis after using Wegovy may be able to file a Wegovy lawsuit and get financial compensation.

One piece of future litigation that is interesting is processed food childhood diabetes lawsuits. Our law firm is not currently handling lawsuits regarding childhood type 2 diabetes and non-alcoholic fatty liver disease linked to ultra-processed foods. But the prospect of future litigation is interesting and worth talking about.

Ulta-Processed Food Diabetes Lawsuit Updates

This litigation is moving forward quite quickly.  Here is the latest news and updates:

This page will look at Saxenda cancer and gastroparesis lawsuits. Saxenda is a weight loss drug that is similar to Ozempic. Several years ago, Saxenda was linked to an increased risk of pancreatic cancer. Now, new evidence has emerged that indicates that Saxenda might also cause a serious condition called gastroparesis (stomach paralysis).

Our firm is currently investigating Saxenda cases from anyone who used Saxenda for at least 6 months and was subsequently diagnosed with gastroparesis. Contact us at 800-553-8082 for a free consultation or get a free case evaluation online. Continue reading

On this page, our national mass tort lawyers will look at Call of Duty video game addiction lawsuits. We will look at the features of Call of Duty that are intended to make it highly addictive, the developer’s failure to warn about the addictive nature of the game and the harmful impacts of video game addiction. We will also look at the allegations and legal claims being made in video game addiction lawsuits across the country, and the potential settlement value of these cases.

• Video Game Addiction Lawsuits
• Roblox Addiction Lawsuits

Mounjaro is a diabetes drug manufactured by Eli Lilly. Recently, Mounjaro (and similar drugs like Ozempic and Wegovy) have become widely used for weight loss and weight management in obese patients. New evidence has emerged, however, showing that using higher doses of Mounjaro for weight loss can cause serious health problems involving the gallbladder and the gastrointestinal system. Mounjaro use has been linked to gallbladder disease, gallstones, gastroparesis (stomach paralysis), and other stomach conditions.

Eli Lilly apparently knew about these dangerous risks associated with Mounjaro but failed to warn doctors and patients about them. Individuals who used Mounjaro and suffered some of these injuries are now bringing Mounjaro product liability lawsuits. The national mass tort lawyers at Miller & Zois are investigating new Mounjaro injury cases. If you took Mounjaro for weight loss and suffered gastroparesis, contact us for a free case evaluation. Call us at 800-553-8082. Continue reading

Veozah (fezolinetant), a non-hormonal drug hailed as a breakthrough for managing menopausal hot flashes, was approved by the FDA in May 2023. Marketed as a safe alternative to hormone replacement therapies, Veozah quickly gained popularity among women seeking relief from debilitating vasomotor symptoms. However, the celebration was short-lived. Reports of severe liver injuries linked to the drug began to surface, prompting FDA interventions and spurring a wave of lawsuits.

Patients allege that Veozah’s manufacturer, Astellas Pharma, failed to adequately warn consumers and healthcare providers about the significant risks associated with its use. As the number of affected individuals grows, legal action is shedding light on the dangers of insufficient drug testing and corporate negligence.

Reverse Chronological Timeline of Key Events